| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
RYTM
Rhythm Pharmaceuticals
|
Jun 15, 2026 | BUY |
Strong Buy
+25.2% avg upside
19 analysts
|
$105.00
8.45% Upside
|
+6.8% |
|
BWAY
Brainsway
|
Jun 15, 2026 | BUY |
Strong Buy
-11.7% avg upside
9 analysts
|
$17.00
14.16% Upside
|
+3.9% |
|
PMN
ProMIS Neurosciences
|
Jun 09, 2026 | BUY |
Strong Buy
+583.1% avg upside
6 analysts
|
$18.00
70.79% Upside
|
· |
|
OVID
Ovid Therapeutics
|
Jun 08, 2026 | BUY |
Strong Buy
+109.1% avg upside
17 analysts
|
$4.00
76.23% Upside
|
· |
|
CRVO
CervoMed
|
Jun 08, 2026 | BUY |
Strong Buy
+398.6% avg upside
9 analysts
|
$25.00
489.69% Upside
|
· |
|
LBRX
LB Pharmaceuticals, Inc.
|
Jun 08, 2026 | BUY |
Strong Buy
+50.0% avg upside
7 analysts
|
$45.00
50.00% Upside
|
-5.1% |
|
COYA
Coya Therapeutics, Inc.
|
Jun 08, 2026 | BUY |
Strong Buy
+225.2% avg upside
7 analysts
|
$18.00
265.78% Upside
|
· |
|
CGTX
Cognition Therapeutics
|
Jun 08, 2026 | BUY |
Strong Buy
+305.1% avg upside
9 analysts
|
$3.00
106.83% Upside
|
+0.0% |
|
ACOG
Alpha Cognition Inc
|
Jun 08, 2026 | BUY |
Strong Buy
+117.1% avg upside
3 analysts
|
$18.00
160.47% Upside
|
· |
|
GANX
Gain Therapeutics
|
Jun 08, 2026 | BUY |
Strong Buy
+318.8% avg upside
9 analysts
|
$8.00
325.48% Upside
|
· |
|
MLTX
MoonLake Immunotherapeutics
|
Jun 08, 2026 | BUY |
Strong Buy
+51.6% avg upside
20 analysts
|
$45.00
134.18% Upside
|
+6.6% |
|
CH:NWRN
Newron Pharmaceuticals SpA
|
Jun 08, 2026 | BUY |
Strong Buy
+262.7% avg upside
3 analysts
|
$44.00
260.68% Upside
|
· |
|
NGEN
NervGen Pharma
|
Jun 08, 2026 | BUY |
Strong Buy
+358.4% avg upside
8 analysts
|
$18.00
718.13% Upside
|
· |
|
FR:ALCOX
Nicox SA
|
Jun 08, 2026 | BUY |
Strong Buy
+1564.5% avg upside
5 analysts
|
$1.00
159.09% Upside
|
· |
|
FR:IPN
Ipsen
|
Jun 05, 2026 | BUY |
Hold
-21.8% avg upside
17 analysts
|
$215.00
37.43% Upside
|
· |
|
VNDA
Vanda
|
Jun 04, 2026 | BUY |
Strong Buy
+254.2% avg upside
13 analysts
|
$21.00
262.09% Upside
|
· |
|
AXSM
Axsome Therapeutics
|
Jun 04, 2026 | BUY |
Strong Buy
-10.5% avg upside
28 analysts
|
$290.00
15.67% Upside
|
+8.8% |
|
URGN
Urogen Pharma
|
Jun 03, 2026 | BUY |
Strong Buy
+13.0% avg upside
16 analysts
|
$45.00
33.97% Upside
|
+23.4% |
|
CH:IDIA
Idorsia Ltd
|
Jun 02, 2026 | BUY |
Hold
-25.6% avg upside
8 analysts
|
$5.00
11.99% Downside
|
· |
|
SPRB
Spruce Biosciences
|
Jun 01, 2026 | BUY |
Strong Buy
+90.8% avg upside
14 analysts
|
$150.00
186.42% Upside
|
-2.7% |
|
CH:SANN
Santhera Pharmaceuticals Holding
|
Jun 01, 2026 | BUY |
Strong Buy
+88.2% avg upside
1 analyst
|
$30.00
88.17% Upside
|
· |
|
INVA
Innoviva
|
Jun 01, 2026 | BUY |
Buy
+27.2% avg upside
12 analysts
|
$46.00
104.63% Upside
|
+5.2% |
|
INO
Inovio Pharmaceuticals
|
Jun 01, 2026 | HOLD |
Strong Buy
+808.3% avg upside
19 analysts
|
$2.50
124.18% Upside
|
-14.1% |
|
EBS
Emergent Biosolutions
|
Jun 01, 2026 | BUY |
Buy
+216.6% avg upside
9 analysts
|
$12.00
49.95% Upside
|
-5.8% |
|
MPLT
MapLight Therapeutics, Inc.
|
May 29, 2026 | BUY |
Strong Buy
+33.6% avg upside
11 analysts
|
$45.00
56.07% Upside
|
-7.3% |
|
BBIO
BridgeBio Pharma
|
May 28, 2026 | BUY |
Strong Buy
+38.7% avg upside
34 analysts
|
$110.00
65.91% Upside
|
-1.6% |
|
ABEO
Abeona Therapeutics
|
May 28, 2026 | BUY |
Strong Buy
+195.8% avg upside
17 analysts
|
$20.00
246.63% Upside
|
· |
|
PLX
Protalix
|
May 26, 2026 | BUY |
Buy
+275.3% avg upside
4 analysts
|
$12.00
440.45% Upside
|
· |
|
VRCA
Verrica Pharmaceuticals
|
May 26, 2026 | BUY |
Strong Buy
+224.8% avg upside
8 analysts
|
$12.00
113.23% Upside
|
· |
|
BNTC
Benitec Biopharma
|
May 26, 2026 | BUY |
Buy
+118.1% avg upside
13 analysts
|
$32.00
163.33% Upside
|
· |
|
CING
Cingulate Inc
|
May 26, 2026 | BUY |
Strong Buy
+365.9% avg upside
5 analysts
|
$20.00
300.80% Upside
|
· |
|
CLYM
Climb Bio
|
May 26, 2026 | BUY |
Strong Buy
+57.9% avg upside
18 analysts
|
$20.00
74.69% Upside
|
· |
|
IKT
Inhibikase Therapeutics
|
May 26, 2026 | BUY |
Strong Buy
+231.2% avg upside
8 analysts
|
$8.00
337.23% Upside
|
· |
|
RMTI
Rockwell Med
|
May 22, 2026 | BUY |
Buy
+1445.2% avg upside
11 analysts
|
$2.00
212.54% Upside
|
-3.8% |
|
FENC
Fennec Pharmaceuticals
|
May 22, 2026 | BUY |
Strong Buy
+78.1% avg upside
9 analysts
|
$16.00
76.51% Upside
|
-9.6% |
|
RVPH
Reviva Pharmaceuticals Holdings
|
May 18, 2026 | HOLD |
Strong Buy
+7085.8% avg upside
9 analysts
|
— | +74.4% |
|
LGVN
Longeveron
|
May 14, 2026 | BUY |
Strong Buy
+5427.8% avg upside
4 analysts
|
$8.00
875.54% Upside
|
· |
|
SEPN
Septerna, Inc.
|
May 13, 2026 | BUY |
Strong Buy
+18.2% avg upside
12 analysts
|
$40.00
10.60% Upside
|
+22.9% |
|
ENTX
Entera Bio
|
May 11, 2026 | BUY |
Strong Buy
+354.6% avg upside
3 analysts
|
$9.00
643.89% Upside
|
+7.7% |
|
ACRS
Aclaris Therapeutics
|
May 11, 2026 | BUY |
Strong Buy
+122.2% avg upside
15 analysts
|
$16.00
255.55% Upside
|
-12.7% |
|
RARE
Ultragenyx Pharmaceutical
|
May 11, 2026 | BUY |
Strong Buy
+142.1% avg upside
36 analysts
|
$50.00
82.31% Upside
|
-12.1% |
|
NAGE
Niagen Bioscience
|
May 11, 2026 | BUY |
Strong Buy
+164.0% avg upside
6 analysts
|
$11.00
214.23% Upside
|
-9.0% |
|
TRDA
Entrada Therapeutics Inc
|
May 08, 2026 | HOLD |
Strong Buy
+198.5% avg upside
10 analysts
|
— | -0.4% |
|
BCPC
Balchem
|
May 04, 2026 | BUY |
Strong Buy
+17.7% avg upside
4 analysts
|
$190.00
14.55% Upside
|
+1.6% |
|
GMAB
Genmab
|
Apr 30, 2026 | BUY |
Buy
+38.3% avg upside
26 analysts
|
$38.00
50.36% Upside
|
+0.1% |
|
CH:GALD
Galderma Group AG
|
Apr 27, 2026 | BUY |
Strong Buy
+5.1% avg upside
10 analysts
|
$260.00
50.80% Upside
|
· |
|
CH:COPN
COSMO Pharmaceuticals N.V.
|
Apr 20, 2026 | BUY |
Strong Buy
+109.2% avg upside
3 analysts
|
$160.00
133.53% Upside
|
· |
|
CH:BIOV
BioVersys AG
|
Apr 17, 2026 | BUY |
Strong Buy
+63.0% avg upside
2 analysts
|
$40.00
48.23% Upside
|
· |
|
MBOT
Microbot Medical
|
Apr 14, 2026 | BUY |
Strong Buy
+260.2% avg upside
7 analysts
|
$12.00
545.06% Upside
|
-29.6% |
|
BTAI
Bioxcel Therapeutics
|
Apr 10, 2026 | BUY |
Buy
+1918.5% avg upside
12 analysts
|
$5.00
316.65% Upside
|
+14.1% |
|
ENLV
Enlivex
|
Apr 07, 2026 | BUY |
Strong Buy
+3492.2% avg upside
4 analysts
|
$20.00
3116.90% Upside
|
-13.8% |
|
AVXL
Anavex Life Sciences
|
Mar 31, 2026 | BUY |
Strong Buy
+782.2% avg upside
9 analysts
|
$20.00
632.58% Upside
|
-17.9% |
|
RGEN
Repligen
|
Mar 23, 2026 | BUY |
Strong Buy
+28.4% avg upside
25 analysts
|
$208.00
57.48% Upside
|
+13.5% |
|
AQST
Aquestive Therapeutics
|
Mar 09, 2026 | BUY |
Strong Buy
+88.9% avg upside
10 analysts
|
$10.00
112.37% Upside
|
+0.4% |
|
AARD
Aardvark Therapeutics, Inc.
|
Mar 02, 2026 | HOLD |
Buy
+386.3% avg upside
12 analysts
|
— | -12.8% |
|
SLGL
Sol-Gel Technologies
|
Jan 20, 2026 | BUY |
Strong Buy
+1.9% avg upside
5 analysts
|
$110.00
47.78% Upside
|
+2.4% |
|
CH:BSLN
Basilea Pharmaceutica
|
Dec 12, 2025 | BUY |
Strong Buy
+42.6% avg upside
6 analysts
|
$105.00
104.58% Upside
|
· |
|
VRNS
Varonis Systems
|
Nov 03, 2025 | HOLD |
Strong Buy
+33.1% avg upside
36 analysts
|
— | -8.8% |
|
FR:MEDCL
MedinCell SA
|
Oct 13, 2025 | BUY |
Strong Buy
+25.5% avg upside
3 analysts
|
$32.00
32.97% Upside
|
· |
|
ANVS
Annovis Bio
|
Sep 03, 2025 | BUY |
Strong Buy
+1309.5% avg upside
7 analysts
|
$10.00
471.37% Upside
|
-0.4% |
|
PCSA
Processa Pharmaceuticals
|
Sep 02, 2025 | BUY |
Strong Buy
+2022.6% avg upside
5 analysts
|
$25.00
1079.22% Upside
|
-43.4% |
|
SER
Serina Therapeutics
|
Aug 28, 2025 | BUY |
Strong Buy
+519.0% avg upside
2 analysts
|
$15.00
614.25% Upside
|
-64.1% |
|
ANEB
Anebulo Pharmaceuticals
|
Aug 11, 2025 | HOLD |
Buy
+796.5% avg upside
5 analysts
|
— | -80.6% |
|
COCP
Cocrystal Pharma
|
Jun 20, 2025 | BUY |
Strong Buy
+704.1% avg upside
2 analysts
|
$6.00
503.09% Upside
|
-6.7% |
|
PYPD
PolyPid
|
Apr 14, 2025 | BUY |
Strong Buy
+248.1% avg upside
7 analysts
|
$11.00
131.99% Upside
|
+85.1% |
|
DMRA
Damora Therapeutics
|
Apr 14, 2025 | HOLD |
Strong Buy
+28.3% avg upside
19 analysts
|
— | · |
|
SPRO
Spero Therapeutics
|
Jan 30, 2025 | BUY |
Buy
+501.5% avg upside
12 analysts
|
$5.00
119.31% Upside
|
+221.8% |
|
RKTO
Rocket One
|
Jan 23, 2025 | BUY |
Strong Buy
+905.3% avg upside
8 analysts
|
$4.00
270.37% Upside
|
· |
|
RKDA
Arcadia Biosciences
|
Jan 13, 2025 | HOLD |
Strong Buy
+1186.3% avg upside
3 analysts
|
— | -81.0% |
|
ADMA
ADMA Biologics
|
Jan 13, 2025 | HOLD |
Strong Buy
+57.2% avg upside
15 analysts
|
— | -48.9% |
|
CRDF
Cardiff Oncology
|
Nov 08, 2024 | BUY |
Strong Buy
+732.8% avg upside
18 analysts
|
$13.00
974.35% Upside
|
-60.7% |
|
SCLX
Scilex Holding Company
|
Oct 21, 2024 | BUY |
Strong Buy
+4351.2% avg upside
5 analysts
|
$245.00
3179.88% Upside
|
-72.9% |
|
INDP
Indaptus Therapeutics
|
Oct 16, 2024 | BUY |
Buy
+2278.1% avg upside
6 analysts
|
$336.00
8515.32% Upside
|
-92.7% |
|
ADXN
Addex Therapeutics
|
Oct 02, 2024 | BUY |
Strong Buy
+383.9% avg upside
1 analyst
|
$30.00
383.95% Upside
|
-24.6% |
|
ORMP
Oramed Pharm
|
Sep 09, 2024 | HOLD |
Strong Buy
+394.8% avg upside
7 analysts
|
— | +72.2% |
|
EQ
Equillium
|
Aug 19, 2024 | BUY |
Strong Buy
+181.9% avg upside
14 analysts
|
$5.00
63.95% Upside
|
+255.1% |
|
ENSC
Ensysce Biosciences
|
Aug 12, 2024 | HOLD |
Buy
+5428.9% avg upside
3 analysts
|
— | -95.7% |
|
RDHL
RedHill Biopharma
|
Aug 12, 2024 | HOLD |
Strong Buy
+2357.6% avg upside
7 analysts
|
— | -90.7% |
|
AVNS
Avanos Medical
|
May 13, 2024 | BUY |
Buy
+9.6% avg upside
5 analysts
|
$23.00
7.74% Downside
|
+24.3% |
|
SRNE
Sorrento Therapeutics
|
Apr 22, 2024 | HOLD |
Strong Buy
+2272627.3% avg upside
7 analysts
|
— | · |
|
GRI
GRI Bio
|
Jan 29, 2024 | HOLD |
Strong Buy
+1017.0% avg upside
3 analysts
|
— | -100.0% |
|
ETON
Eton Pharmaceuticals
|
Dec 11, 2023 | BUY |
Strong Buy
-21.5% avg upside
8 analysts
|
$10.00
69.17% Downside
|
+329.5% |
|
RNAC
Cartesian Therapeutics
|
Aug 18, 2023 | BUY |
Strong Buy
+228.2% avg upside
19 analysts
|
$150.00
1457.68% Upside
|
-66.7% |
|
NMTRQ
9 Meters Biopharma
|
Jul 24, 2023 | HOLD |
Buy
+3234374900.0% avg upside
11 analysts
|
— | · |
|
TSE:CSCI
COSCIENS Biopharma
|
May 12, 2023 | BUY |
Strong Buy
+472.1% avg upside
8 analysts
|
$39.63
1216.58% Upside
|
· |
|
FATE
Fate Therapeutics
|
May 05, 2023 | HOLD |
Buy
+475.7% avg upside
31 analysts
|
$7.00
234.83% Upside
|
-79.4% |
|
TSE:BHC
Bausch Health Companies
|
Mar 27, 2023 | HOLD |
Buy
+809.1% avg upside
29 analysts
|
— | · |
|
OMER
Omeros
|
Mar 27, 2023 | HOLD |
Buy
+111.2% avg upside
14 analysts
|
— | +121.3% |
|
INM
InMed Pharmaceuticals
|
Feb 27, 2023 | HOLD |
Hold
+1242.4% avg upside
3 analysts
|
— | -89.1% |
|
EVFM
Evofem Biosciences
|
Feb 27, 2023 | HOLD |
Buy
+269017.6% avg upside
8 analysts
|
— | · |
|
OBSEF
ObsEva
|
Feb 24, 2023 | HOLD |
Buy
+10799900.0% avg upside
8 analysts
|
— | · |
|
GRTX
Galera Therapeutics
|
Feb 16, 2023 | BUY |
Buy
+6826.1% avg upside
7 analysts
|
$10.00
11568.62% Upside
|
· |
|
AU:CYP
Cynata Therapeutics Limited
|
Jan 23, 2023 | HOLD |
Hold
1 analyst
|
— | · |
|
MTVA
MetaVia
|
Jan 04, 2023 | HOLD |
Strong Buy
+1769.3% avg upside
13 analysts
|
— | -64.3% |
|
SYBX
Synlogic
|
Dec 16, 2022 | BUY |
Buy
+3290.3% avg upside
11 analysts
|
$105.00
14688.67% Upside
|
-86.3% |
|
XCUR
Exicure
|
Oct 03, 2022 | HOLD |
Buy
+3990.9% avg upside
4 analysts
|
— | -67.2% |
|
AVTX
Avalo Therapeutics
|
Oct 03, 2022 | HOLD |
Strong Buy
+265.1% avg upside
19 analysts
|
— | -98.8% |
|
ELTX
Elicio Therapeutics
|
Jul 26, 2022 | HOLD |
Buy
+393.5% avg upside
11 analysts
|
— | -55.1% |
|
IMUX
Immunic
|
Feb 04, 2022 | BUY |
Strong Buy
+166.0% avg upside
21 analysts
|
$25.00
75.96% Upside
|
-90.9% |
|
NCNA
Nucana
|
Nov 24, 2021 | BUY |
Buy
+559.7% avg upside
9 analysts
|
$9.00
371.27% Upside
|
-82.8% |
|
KALA
KALA BIO
|
May 06, 2021 | BUY |
Strong Buy
+5804.2% avg upside
9 analysts
|
$14.00
287.85% Upside
|
-94.2% |
|
EYPT
EyePoint Pharmaceuticals
|
May 06, 2021 | BUY |
Strong Buy
+123.7% avg upside
17 analysts
|
$15.00
10.47% Upside
|
-31.7% |
|
CH:ADXN
Addex Therapeutics
|
Apr 21, 2021 | BUY |
Strong Buy
+49025.1% avg upside
1 analyst
|
$22.60
49025.14% Upside
|
· |
|
HYPD
Hyperion DeFi
|
Apr 01, 2021 | BUY |
Strong Buy
+143.0% avg upside
8 analysts
|
$8.00
131.91% Upside
|
· |
|
ORIC
Oric Pharmaceuticals
|
Mar 25, 2021 | BUY |
Strong Buy
+180.3% avg upside
19 analysts
|
$54.00
536.05% Upside
|
-78.4% |
|
CRMD
Cormedix
|
Mar 10, 2021 | BUY |
Strong Buy
+73.5% avg upside
13 analysts
|
$10.00
15.29% Upside
|
-54.6% |
|
RVMD
Revolution Medicines
|
Mar 03, 2021 | BUY |
Strong Buy
-12.3% avg upside
32 analysts
|
$55.00
66.33% Downside
|
-39.0% |
|
TLSA
Tiziana Life Sciences
|
Feb 03, 2021 | BUY |
Strong Buy
+481.9% avg upside
5 analysts
|
$11.00
848.33% Upside
|
-85.9% |
|
PPBT
Purple Biotech
|
Dec 31, 2020 | BUY |
Strong Buy
+2155.0% avg upside
4 analysts
|
$25.00
1370.69% Upside
|
-63.8% |
|
CELC
Celcuity
|
Dec 24, 2020 | BUY |
Strong Buy
+40.6% avg upside
16 analysts
|
$14.00
84.01% Downside
|
-53.3% |
|
CODX
Co-Diagnostics
|
Aug 14, 2020 | BUY |
Buy
+486.1% avg upside
5 analysts
|
$33.00
879.15% Upside
|
-72.5% |
|
KRMD
REPRO-MED Systems
|
Aug 10, 2020 | BUY |
Strong Buy
+65.0% avg upside
9 analysts
|
$16.00
310.23% Upside
|
-74.0% |
|
BNTX
BioNTech SE
|
Jun 30, 2020 | HOLD |
Strong Buy
+50.5% avg upside
26 analysts
|
— | +126.4% |
|
BLFS
BioLife Solutions
|
Jun 04, 2020 | BUY |
Strong Buy
+12.9% avg upside
17 analysts
|
$17.00
34.73% Downside
|
-13.2% |
|
OGEN
Oragenics
|
Jun 02, 2020 | HOLD |
Buy
+173.1% avg upside
3 analysts
|
— | -41.1% |
|
IRWD
Ironwood Pharma
|
Jun 01, 2020 | HOLD |
Buy
+235.6% avg upside
23 analysts
|
$11.00
210.74% Upside
|
+15.3% |
|
BDTX
Black Diamond Therapeutics
|
May 04, 2020 | BUY |
Strong Buy
+984.3% avg upside
12 analysts
|
$53.00
3092.82% Upside
|
-93.6% |
|
SRTS
Sensus Healthcare
|
Feb 14, 2020 | BUY |
Strong Buy
+142.0% avg upside
8 analysts
|
$8.00
186.75% Upside
|
+94.4% |
|
CTMX
CytomX Therapeutics
|
Dec 20, 2019 | BUY |
Strong Buy
+269.6% avg upside
21 analysts
|
$14.00
374.65% Upside
|
-26.6% |
|
REPL
Replimune Group
|
Nov 12, 2019 | BUY |
Hold
+72.3% avg upside
13 analysts
|
$26.00
155.17% Upside
|
+100.2% |
|
TTOO
T2 Biosystems
|
May 31, 2019 | BUY |
Buy
+1421150.0% avg upside
10 analysts
|
$10.00
1999899.99% Upside
|
· |
|
OCUL
Ocular Therapeutix
|
May 30, 2019 | BUY |
Strong Buy
+160.4% avg upside
21 analysts
|
$9.00
4.49% Downside
|
+491.9% |
|
GRDX
GridAI Technologies
|
May 24, 2019 | BUY |
Strong Buy
+275.0% avg upside
7 analysts
|
$7.00
29.65% Upside
|
-61.9% |
|
CFOR
CapForce
|
May 17, 2019 | BUY |
Buy
+500.0% avg upside
3 analysts
|
$30.00
757.10% Upside
|
· |
|
VERU
Veru
|
May 16, 2019 | BUY |
Strong Buy
+568.5% avg upside
10 analysts
|
$4.50
52.50% Upside
|
+372.5% |
|
MBAI
Check-Cap
|
May 15, 2019 | BUY |
Strong Buy
+482.7% avg upside
5 analysts
|
$15.00
948.89% Upside
|
· |
|
IDXG
Interpace Diagnostics Group
|
May 14, 2019 | BUY |
Strong Buy
+617.5% avg upside
9 analysts
|
$35.00
1999.61% Upside
|
· |
|
HTGMQ
HTG Molecular Diagnostics
|
May 13, 2019 | BUY |
Buy
+7333233.3% avg upside
6 analysts
|
$8.00
7999900.02% Upside
|
· |
|
WHWK
Whitehawk Therapeutics
|
May 10, 2019 | HOLD |
Buy
+201.4% avg upside
12 analysts
|
— | -1.9% |
|
CDNA
CareDx
|
May 09, 2019 | BUY |
Buy
+25.1% avg upside
16 analysts
|
$43.00
64.30% Upside
|
+136.2% |
|
CYDY
CytoDyn
|
May 08, 2019 | BUY |
Buy
+457.6% avg upside
2 analysts
|
$1.50
457.60% Upside
|
+592.9% |
|
XRAY
DENTSPLY SIRONA
|
May 06, 2019 | HOLD |
Buy
+170.6% avg upside
25 analysts
|
$55.00
432.51% Upside
|
+25.1% |
|
GENNQ
Genesis Healthcare
|
Apr 18, 2019 | BUY |
Buy
+53914710.0% avg upside
5 analysts
|
$253.20
253203950.00% Upside
|
· |
|
GB:0MGB
Genmab A/S
|
Apr 02, 2019 | BUY |
Buy
+31.6% avg upside
22 analysts
|
$1650.00
0.53% Upside
|
· |
|
SDEV
Stablecoin Development Corp
|
Mar 29, 2019 | HOLD |
Buy
+5.8% avg upside
7 analysts
|
$1.00
18.01% Downside
|
· |
|
SNY
Sanofi
|
Feb 26, 2019 | BUY |
Strong Buy
+74.5% avg upside
20 analysts
|
— | +19.8% |
|
AEMD
Aethlon Medical
|
Feb 14, 2019 | BUY |
Buy
+755.3% avg upside
3 analysts
|
$45.00
2280.87% Upside
|
-82.4% |
|
LADX
LadRx
|
Feb 05, 2019 | BUY |
Strong Buy
+6535.5% avg upside
5 analysts
|
$4.50
4105.56% Upside
|
· |
|
QNRX
Quoin Pharmaceuticals
|
Dec 12, 2018 | BUY |
Strong Buy
+661.3% avg upside
7 analysts
|
$60.00
1190.28% Upside
|
-85.4% |
|
KPRX
Kiora Pharmaceuticals
|
Nov 14, 2018 | BUY |
Strong Buy
+253.8% avg upside
6 analysts
|
$6.00
137.15% Upside
|
-46.4% |
|
ONCSQ
OncoSec Medical
|
Nov 07, 2018 | HOLD |
Strong Buy
+4699999900.0% avg upside
9 analysts
|
$10.00
999999899.94% Upside
|
· |
|
JNJ
Johnson & Johnson
|
Oct 17, 2018 | BUY |
Strong Buy
-3.5% avg upside
36 analysts
|
— | +12.1% |
|
AIXC
AIxCrypto Holdings
|
Oct 15, 2018 | BUY |
Strong Buy
+653.4% avg upside
7 analysts
|
$15.00
927.38% Upside
|
· |
|
PHIO
Phio Pharmaceuticals
|
Oct 15, 2018 | BUY |
Strong Buy
+822.3% avg upside
3 analysts
|
— | -91.3% |
|
LSTA
Lisata Therapeutics
|
Sep 10, 2018 | BUY |
Buy
+267.9% avg upside
11 analysts
|
$15.00
326.04% Upside
|
-68.1% |
|
IMRN
Immuron
|
Jul 25, 2018 | BUY |
Strong Buy
+1786.8% avg upside
1 analyst
|
$20.00
1786.82% Upside
|
+10.1% |
|
HURA
TuHURA Biosciences
|
Jun 27, 2018 | BUY |
Strong Buy
+258.0% avg upside
8 analysts
|
$12.00
366.84% Upside
|
-89.7% |
|
IPCIQ
IntelliPharmaCeutics International
|
May 29, 2018 | BUY |
Buy
+1649999899.9% avg upside
4 analysts
|
$25.00
2499999899.93% Upside
|
· |
|
VNRX
VolitionRX
|
Mar 05, 2018 | BUY |
Strong Buy
+590.6% avg upside
11 analysts
|
$10.00
599.30% Upside
|
+29.0% |
|
SEELQ
Seelos Therapeutics
|
Feb 19, 2018 | HOLD |
Buy
+46385614.3% avg upside
10 analysts
|
$30.00
29999899.92% Upside
|
-96.8% |
|
CANF
Can-Fite BioPharma
|
Feb 01, 2018 | BUY |
Strong Buy
+57.3% avg upside
8 analysts
|
$6.00
101.27% Upside
|
-93.6% |
|
BPTH
Bio-Path Holdings
|
Nov 13, 2017 | BUY |
Strong Buy
+22332.4% avg upside
6 analysts
|
$1.50
3954.06% Upside
|
· |
|
RGRX
RegeneRx Biopharmaceuticals
|
Nov 01, 2017 | BUY |
Strong Buy
+249899.9% avg upside
1 analyst
|
$1.50
249899.93% Upside
|
· |
|
JAGX
Jaguar Animal Health
|
Jul 11, 2017 | BUY |
Strong Buy
+108.3% avg upside
5 analysts
|
$2.00
11.21% Downside
|
-99.4% |
|
AYTU
Aytu BioScience
|
Jul 06, 2017 | BUY |
Strong Buy
+700.8% avg upside
7 analysts
|
$50.00
2064.44% Upside
|
-99.2% |
|
HROW
Harrow Health
|
May 11, 2017 | BUY |
Strong Buy
+25.2% avg upside
12 analysts
|
$5.00
88.32% Downside
|
+27.5% |
|
DRIO
DarioHealth
|
Mar 27, 2017 | BUY |
Strong Buy
+22.7% avg upside
5 analysts
|
$8.00
15.45% Upside
|
-81.5% |
|
GYRE
Gyre Therapeutics
|
Dec 12, 2016 | BUY |
Strong Buy
+212.0% avg upside
15 analysts
|
$30.00
380.03% Upside
|
+11.8% |
|
BIOCQ
Biocept
|
Nov 10, 2016 | BUY |
Strong Buy
+42037400.0% avg upside
7 analysts
|
$2.25
1124899.91% Upside
|
· |
|
OTLC
Oncotelic Therapeutics
|
Aug 22, 2016 | BUY |
Strong Buy
+7468.0% avg upside
5 analysts
|
$2.00
4027.95% Upside
|
· |
|
VRDN
Viridian Therapeutics
|
May 17, 2016 | BUY |
Strong Buy
+103.7% avg upside
32 analysts
|
$4.00
75.98% Downside
|
-20.1% |
|
NSPR
InspireMD
|
May 11, 2016 | BUY |
Strong Buy
+447.3% avg upside
8 analysts
|
$3.00
322.58% Upside
|
-99.7% |
|
PALI
Palisade Bio
|
Jun 29, 2015 | BUY |
Strong Buy
+1347.1% avg upside
15 analysts
|
$6.00
220.78% Upside
|
-74.9% |
|
CPRX
Catalyst Pharma
|
Jun 24, 2015 | BUY |
Strong Buy
-17.0% avg upside
15 analysts
|
$14.00
55.31% Downside
|
-31.2% |
|
CTSO
Cytosorbents
|
May 12, 2015 | BUY |
Strong Buy
+2611.9% avg upside
13 analysts
|
$21.00
4691.34% Upside
|
-37.5% |
|
ARCT
Arcturus Therapeutics
|
Nov 17, 2014 | HOLD |
Buy
+290.9% avg upside
35 analysts
|
— | -37.1% |
|
SCPX
Scorpius Holdings
|
Oct 02, 2014 | BUY |
Strong Buy
+1664672.8% avg upside
11 analysts
|
$22.00
1999900.05% Upside
|
· |
|
ALT
Altimmune
|
Sep 16, 2014 | BUY |
Strong Buy
+935.8% avg upside
19 analysts
|
$6.00
122.14% Upside
|
· |
|
GALT
Galectin Therapeutics
|
Aug 01, 2014 | HOLD |
Strong Buy
+245.1% avg upside
8 analysts
|
— | -66.3% |
|
BLRX
Bioline RX Ltd Sponsored ADR
|
May 21, 2014 | BUY |
Strong Buy
+222.8% avg upside
6 analysts
|
$7.00
121.59% Upside
|
-53.6% |
|
AMRN
Amarin
|
May 12, 2014 | HOLD |
Buy
-47.3% avg upside
18 analysts
|
$2.00
87.46% Downside
|
· |
|
AMPE
Ampio Pharmaceuticals
|
Mar 17, 2014 | BUY |
Buy
+9184.6% avg upside
4 analysts
|
$16.00
8638.44% Upside
|
-58.3% |
|
NAVBQ
Navidea
|
Mar 06, 2014 | HOLD |
Buy
+2833233.3% avg upside
4 analysts
|
$2.50
2499900.03% Upside
|
· |
|
CORBF
Global Cord Blood
|
Feb 25, 2014 | BUY |
Strong Buy
+785.1% avg upside
3 analysts
|
$7.00
636.13% Upside
|
· |
|
SVA
Sinovac Biotech
|
Nov 13, 2013 | BUY |
Strong Buy
1 analyst
|
$7.00
|
· |
|
ROSGQ
Rosetta Genomics
|
Oct 30, 2013 | HOLD |
Buy
+449999900.0% avg upside
4 analysts
|
$3.50
349999899.96% Upside
|
· |
|
RIOT
Riot Platforms
|
Aug 19, 2013 | BUY |
Strong Buy
+0.2% avg upside
28 analysts
|
$28.00
0.39% Downside
|
· |
|
SLS
SELLAS Life Sciences Group
|
Nov 28, 2012 | BUY |
Strong Buy
+768.2% avg upside
15 analysts
|
$6.00
25.49% Downside
|
-0.6% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.